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Abstract
OBJECTIVES—To determine whether participation in a physical activity benefit by Medicare
managed care enrollees is associated with lower healthcare utilization and costs.
DESIGN—Retrospective cohort study.
SETTING—Medicare managed care.
PARTICIPANTS—A cohort of 1,188 older adult health maintenance organization enrollees who
participated at least once in the EnhanceFitness (EF) physical activity benefit and a matched group
of enrollees who never used the program.
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MEASUREMENTS—Healthcare costs and utilization were estimated. Ordinary least squares
regression was used, adjusting for demographics, comorbidity, indicators of preventive service
use, and baseline utilization or cost. Robustness of findings was tested in sensitivity analyses
involving continuous propensity score adjustment and generalized linear models with nonconstant
variance assumptions.
RESULTS—EF participants had similar total healthcare costs during Year 1 of the program, but
during Year 2, adjusted total costs were $1,186 lower (P=.005) than for non-EF users. Differences
were partially attributable to lower inpatient costs (−$3,384; P=.02), which did not result from
high-cost outliers. Enrollees who attended EF an average of one visit or more per week had lower
adjusted total healthcare costs in Year 1 (−$1,929; P<.001) and Year 2 (−$1,784; P<.001) than
nonusers.
CONCLUSION—Health plan coverage of a preventive physical activity benefit for seniors is a
promising strategy to avoid significant healthcare costs in the short term.
Keywords
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Healthcare expenditures for seniors are projected to increase more than three times as fast as
the U.S. gross domestic product over the next 25 years.1,2 Much of the growth in healthcare
spending is attributable to increased diagnosis and more-intensive management of leading
chronic illnesses.2 Chronic illnesses are on the rise, in part, because of increasing trends in
unhealthy lifestyle behaviors, including physical inactivity.3-8 Physical inactivity increases
with age; only 39% of adults aged 65 and older report participating in regular moderate or
vigorous physical activity, compared with approximately 50% of adults aged 35 to 54.9
In an attempt to lower expenditures without restricting coverage, some health plans are
expanding prevention benefits to include formal physical activity and weight-management
programs that target behaviors most closely linked to the development and progression of
chronic disease. These programs provide behavioral skills, social support, and problem
solving to promote participation in healthier lifestyles well beyond just attendance in formal
program sessions.
Because lifestyle interventions can be costly to finance, health plans have great interest in
assessing whether coverage of a physical activity benefit is financially sustainable. Past
research in this area has been limited.10-20 One strategy used in past research to assess
financial sustainability was to determine whether the health benefits attributable to a
program translated into lower future healthcare expenditures. These prior studies have been
limited by short follow-up periods (6–12 months) or a lack of available data to address
potential sources of bias and confounding when programs are offered in real-world settings.
The healthcare costs of older adult Medicare managed care beneficiaries participating in an
elective, community-based group exercise program called LifetimeFitness (now
EnhanceFitness (EF)) were compared with those of a cohort of otherwise similar health plan
enrollees who did not participate.10 Total annualized healthcare costs of users and nonusers
were similar, but members who used the program at least once per week on average had
significantly lower total and inpatient healthcare costs than nonusers.10
That prior study adjusted for differences in other member-level demographic and clinical
characteristics associated with differences in future healthcare costs, but the approach had
some important limitations. First, data were available only to evaluate average differences in
healthcare costs for the first 12 months after enrollees began participating in the EF
program. Because many of the expected health benefits of physical activity participation
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take time to accrue, the 12-month time frame may have been too short to identify
meaningful health improvements that could lead to lower future costs. Second, data
regarding the propensity of individual enrollees to engage in healthy and preventive
behaviors were not available. Members who take an active interest in preventive services are
more likely to participate in an elective physical activity benefit and may be more likely to
have lower future healthcare expenditures, regardless of EF use. Thus, this new study was
conducted to extend our prior analyses by examining the association between EF
participation and healthcare utilization and costs beyond 1 year and incorporating
information about the use of other preventive services to reduce the potential for residual
confounding and selection bias.
METHODS
Study Setting and Participants
This retrospective cohort study was conducted with members of Group Health Cooperative
of Puget Sound (GHC), a large mixed-model health maintenance organization in
Washington state that enrolls nearly 60,000 Medicare beneficiaries. All Medicare enrollees
who were aged 65 and older, were enrolled in GHC between October 1, 1997, and
December 31, 2004, and elected to participate in EF at least once were sampled (1,676
members).
EF is a group-based exercise program that meets three times per week and is offered to
community-dwelling older adults at more than 30 community-based sites in the Seattle/
Puget Sound area. Certified fitness instructors teach the program, which is designed to
increase health and functional abilities of relatively sedentary older adults. All classes follow
a standardized format of 5 minutes of warm up, 20 to 25 minutes of moderate-intensity
aerobics, 20 minutes of resistance strength training, and 10 minutes of flexibility and
balance training. In addition to providing direct supervision of light-to-moderate to moderate
physical activities, the EF program provides regular ongoing contact with health plan
members to build self-efficacy and experience with new physical activities and to provide
social support to promote participation in healthier lifestyles that are expected to extend well
beyond attendance in formal program sessions.21 Since October 1998, GHC has paid the
per-visit costs for all of its Medicare-eligible enrollees who elect to participate in the EF
program.
Using a 3:1 age- and sex-frequency-matching procedure, 5,027 members who met the age
and enrollment criteria for EF but did not attend a single visit were identified as controls.
Each EF participant was assigned an index date equating to the first day of the month in
which they first visited an EF class. Similarly, the same index date was assigned to each
matched control to create similar pre-exposure and follow-up time periods. After excluding
members who had baseline long-term care utilization, who were missing RxRisk
comorbidity indicator data, who disenrolled from the health plan, or who were missing total
cost data during the first year after their index date, the final sample consisted of 1,188 EF
users and 2,462 matched controls. RxRisk is a measure of chronic disease burden and
comorbidity that has been previously shown to explain as much variation in total healthcare
costs as ambulatory care groups.22,23 Institutional review boards at the University of
Washington and Group Health Cooperative of Puget Sound approved the study protocol.
Measures and Data Sources
The primary analysis addressed the effect of EF participation on differences in total
healthcare costs over 2 years. Secondary measures of program effectiveness included
inpatient hospitalization and costs, primary care visits and costs, and specialty care visits and
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costs. The source of cost estimates was the GHC administrative Decision Support System,
which integrates clinical information, units of service, and actual costs from the general
ledger for 15 separate feeder systems. GHC identifies all costs as direct patient care costs or
overhead costs (those shared by more than one department). All overhead costs are fully
allocated to individual patient care departments. Departments captured in the database
include medical staff, nursing, pharmacy, laboratory, radiology, hospital inpatient, and
community health services. Units of service are weighted using relative value units for
ancillary departments, technical relative value units for radiology, College of Anatomical
Pathology units for laboratory, and visit length for outpatient visits. From this process, the
cost for each unit of service delivered is then calculated, and costs are assigned to patients
based on units of service used. To provide estimates that reflect present-day healthcare costs,
all costs were scaled to 2005 U.S. dollars using consumer price index multipliers specifically
for the medical care sector.24
The independent variables included age and sex, RxRisk, an indicator of whether an enrollee
had any arthritis visits in the previous year, indicators of whether they were included in
GHC's heart disease or diabetes mellitus disease registry, and baseline (pre-index) cost and
utilization. GHC programmers used age, sex, and pharmacy utilization data for a 6-month
period before the index date to calculate RxRisk values for each member.23 A “prevention
score” was also constructed for each individual, based on the sum of the number of times a
member received colon cancer screening (fecal occult blood test or flexible sigmoidoscopy),
a screening mammogram, prostate cancer screening, an influenza vaccine, or a
pneumococcal vaccine during the 2 years preceding the index date (range 0–8).
Data Analysis
Ordinary least squares (OLS) regression was used to model utilization and costs, because
OLS generates unbiased treatment effect estimates in large data sets (≥500 observations),
even when assumptions about normality and homoskedasticity are not met.25 For analyzing
inpatient costs, when a large percentage of individuals had no related expenses during the
follow-up period, a logistic model was first used to compare proportions hospitalized, and
then an OLS model was used to estimate inpatient costs only for individuals who had one or
more inpatient utilizations. A dummy variable was entered for EF exposure status in each
model to estimate the cost and utilization differences between study groups. In all regression
models, covariates were included for age, sex, RxRisk, prevention score, inclusion in the
GHC heart disease and diabetes mellitus registries, history of any arthritis visits, and the
baseline value of the dependent utilization or cost variable. Adjustment for baseline cost or
utilization outcome differences addressed the potential for confounding and is a method to
avoid bias from regression to the mean.26
Because many of the health benefits of physical activity are likely to have a dose-dependent
relationship,27,28 an evaluation was performed to test if regular use of EF (≥1 visit/week)
was associated with lower healthcare costs, when compared to members who were nonusers
(controls) or lower-level users. Average attendance per week was calculated by adding all
EF visits across the year and dividing by 52. “Higher” EF use was defined as 52 or more
visits in the first 12 months after the index date (i.e., an average rate of 1 visits/week),
because this was congruent with the definition used in a prior analysis of EF.10 All
remaining EF users (those with average attendance <1 visit/week) were classified as “lower”
users.
The partial regression coefficient for EF use from each OLS regression model was added to
(or subtracted from) the unadjusted mean outcome value for EF nonusers to obtain the
adjusted means for EF users. All presented P-values are from OLS models and use robust
standard error estimates that did not require distributional assumptions to be exact.
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Statistical procedures were conducted using Stata 9.0 statistical data analysis software (Stata
Corp., College Station, TX).
Sensitivity Analyses
Two sensitivity analyses were performed. First, models were rerun using a propensity score
(PS) quintile with regression adjustment approach to improve balance in observed covariates
and reduce potential selection bias,31 based on a logit model to generate each patient's
propensity of being in the high or low EF user subgroups. The PS was then entered as an
additional covariate in the regression models, but inclusion did not change the statistical
significance or relative magnitude of estimates for any cost or utilization outcomes. Thus,
non-PS-adjusted models are presented to provide the most straightforward estimates of
absolute cost and utilization differences between groups.
Second, cost and utilization outcomes were estimated using generalized linear models with a
gamma (costs) or negative binomial (utilization) distribution assumption and a log-link
function to assess whether the choice of estimation approach affected the results.29 There
were no major differences in the magnitude or statistical significance of cost or utilization
effects, so the OLS model results are presented in the remainder of this article.
RESULTS
EF users and controls were of similar age and sex and had comparable comorbidity
(RxRisk) scores (Table 1), although EF users were somewhat more likely to be in the GHC
heart disease registry (20.4% of EF users; 16.8% of controls; P=.007) and to have any
arthritis visits (19.6% of EF users; 16.6% of controls; P=.02). EF users also had
approximately 0.5 more visits to primary care and to specialty care providers (P<.001).
Moreover, they received 0.5 more preventive services (2.3 vs 1.8; P<.001) over the 2 years
before EF use. Annual total healthcare costs at baseline for EF users were approximately
$586 higher than for controls ($5,963 vs $5,377; P=.048), with more than half of this cost
difference attributable to higher primary care and specialty care costs.
Cost and Utilization Difference Between All EF Users and Controls
Predicted differences in costs and utilization summary measures between all EF users and
matched controls are shown in Table 2. During the first 12 months after their index date, EF
users had a lower hospitalization rate but more primary care visits and higher primary care
costs than members who never used EF; total and specialty care costs over the first year
were not significantly different between groups. During the second year (13–24 months after
the index date), EF users still had higher predicted primary care costs than controls, but they
had significantly lower inpatient and total health-care costs (difference: controls–EF users=
$1,186; P=.005).
Effect of Attendance Level on Cost and Utilization Differences
Of the 1,188 EF users, 539 (45%) had an average of one or more visits per week during the
first 12 months of use. During this period, lower EF users had more predicted primary and
specialty care visits and higher primary care costs than nonusers; total, inpatient, and
specialty care costs were similar (Table 3). Conversely, higher EF users had no difference in
predicted primary care and specialty care visits but significantly fewer hospitalizations
(13.6% vs 14.3%; P<.001), lower adjusted specialty care costs, and lower adjusted total
healthcare costs ($1,929 lower; P<.001) than nonusers over the same time period.
The delayed effects of EF use were next explored by comparing healthcare cost and
utilization data for members who were high or low EF users during Year 1 and remained
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continuously enrolled in GHC for a second full year (13–24 months after the index visit
date). During Year 2, participants who had been lower EF users during Year 1 continued to
have more predicted specialty care visits and higher primary care costs than nonusers.
Lower EF users also had significantly lower inpatient costs than controls, but specialty and
total healthcare costs were similar. During Year 2, higher EF users continued to have
significantly fewer hospitalizations (12.9% vs 13.4%; P=.009) and lower predicted total
healthcare costs ($1,784 lower; P<.001) than nonuser controls.
DISCUSSION
Medicare managed care members who elected to participate in a community-based physical
activity benefit (EF) had similar predicted total healthcare costs in the first year after visiting
the program and significantly lower total costs (~$1,200 lower; P=.005) in the second year
than age- and sex-matched health plan members who did not participate. These differences
were largely attributable to significantly lower inpatient costs for EF users that were not
simply explained by differences in high-cost outliers.
Evidence was also found of a program “dose” effect. After adjustment, lower EF users had
more primary and specialty care visits than nonusers and similar total costs during the 2
years after their first EF visit. Conversely, more-frequent users of EF had fewer
hospitalizations and lower total healthcare costs than nonusers during the first 12 months
after beginning EF and persistent differences in total healthcare costs during the second year
after beginning the program. In the absence of strong randomized trials demonstrating
improvements in health after initiation of a community-based physical activity health
benefit, these findings may be the most compelling evidence available that health plan
coverage and use of a preventive health benefit by seniors can help to improve health and
return short-term cost savings.
This study had some notable limitations. First, information was available only about the
number of EF visits for each user and not about other sources of physical activity
participation. As such, the current analysis cannot disentangle the benefits of EF visits from
changes in physical activity occurring outside of the program, nor can it differentiate
differences between higher use for short periods (e.g., visits twice per week for 6 months)
from more consistent use at lower frequencies (e.g., visits once per week for 12 months).
However, because EF program sessions meet approximately once weekly, it is likely that
changes in lifestyle behaviors that occur outside of formal program visits may mediate
potential health benefits resulting from EF program use. Changes in physical activity and
other lifestyle behaviors have been observed in prior research of lifestyle interventions that
do not include supervised physical activity and may result from the development of
behavioral skills and social support in association with regular program visits.30 Regardless
of the exact mechanism for how EF use might improve the health of participants, exposure
to this program appears to be a strong independent predictor of lower future healthcare
expenditures in older adults. Second, information was not available about all variables that
might confound associations between EF use and healthcare consumption (e.g., tobacco use,
diet, other sources of physical activity). To reduce confounding and selection bias, covariate
adjustment with several indicators of comorbidity, health status, and past use of elective
preventive services was used. Sensitivity analyses were also performed using PS quintiles
with adjustment, and similar results were obtained.31,32 Although these data offer robust
information about overall health and the prevention-seeking profile of each member, it is
always possible that these methods were incomplete in adjustment for selection bias. Third,
reverse causality is possible when exposure (the frequency of EF visits) is determined over
the same period as the outcome (healthcare costs and utilization). To avoid reverse causality,
healthcare cost and utilization outcomes were compared during Year 2 for groups with
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different EF “dosage” levels during Year 1 (i.e., before the measurement of outcomes). In
adjusted models, members using EF at least once during Year 1 had total costs during Year
2 that were $1,186 (P=.005) lower than those of nonusers; those who used EF at least once
per week during Year 1 had total costs during Year 2 that were $1,784 (P<.001) lower than
those of non-users.
Given the ability of this analysis to incorporate longitudinal cost data and to use more-robust
health plan data to adjust for differences in overall health-seeking behaviors of members, the
results of this study provide the strongest evidence available to date that health plan efforts
to offer coverage for an elective, group-based physical activity benefit for older adult
members has the potential to offer return on investment in the short term. The potential for
cost recovery will depend highly on the per-member costs of offering the program and the
proportion of participating members who use the benefit regularly. Although greater
program use will generate higher charges from EF program sites, these analyses suggest that
savings may be possible only with regular program use. Thus, one unanswered question
arising from this study is whether efforts to increase program participation by non-use and
low-use members will result in similarly lower total healthcare costs as those observed in
elective high users. Because efforts to promote higher program use are likely to generate
additional costs for a health plan, it will also be worthwhile to consider the extent to which
reduced future healthcare costs will offset additional programmatic costs (i.e., to promote
adoption and maintenance). Answering these questions in the context of a large, group-
randomized trial would require numerous health plans and considerable evaluation resources
and is, thus, not likely to be forthcoming. To address these issues in a more-practical
context, it will be important for health plans to collect information about the costs invested
in efforts to increase use of community-based lifestyle benefits, as well as all cost inputs
required to offer such a program for its members. Until then, this study provides valuable
information for policy makers who may be considering whether to provide coverage for a
community-based, group physical activity benefit for older adults.
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Users (n = 1,188)
Demographic
 Age, mean 75.4 75.7
 Female, % 77.0 75.5
Comorbidity measures
 RxRisk comorbidity score, $* 2,770 2,676
 High-density lipoprotein cholesterol, mg/dL, mean 56.1 (n = 855) 57.3 (n = 473)
 Triglycerides, mg/dL, mean 200 (n = 564) 178 (n = 328)
 Hemoglobin A1c, mg/dL, mean† 7.5 (n = 323) 7.4 (n = 132)
 Diabetes mellitus, % 14.2 12.1
 Existing cardiovascular disease, % 16.8 20.4
 Any arthritis visits, % 16.6 19.6
Utilization measures
 Hospitalized, % 10.1 10.4
 Primary care visits/year, mean 4.9 5.5
 Specialty care visits/year, mean 2.9 3.4
 Prevention score, mean‡ 1.8 2.3
Cost measures, 2005 dollars, mean
 Total 5,377 5,963
 Inpatient§ 11,929 11,656
 Primary care 914 1,082
 Specialty care 789 949
*
A measure of chronic disease burden and comorbidity that has been previously shown to explain as much variation in total healthcare costs as
ambulatory care groups.
†
Only for individuals in diabetes mellitus registry.
‡
Prevention sum is the total of preventative services that the individual used in the previous 2 years (see text; range 0–8).
§
For individuals who had any inpatient utilization.
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Table 2
Predicted Annual Adjusted Costs and Utilization After at Least One Visit to the EnhanceFitness (EF) Program
Outcome Controls EF Users Mean Difference (EF Users–Controls) P-Value
Year 1, n* 2,462 1,188
 Utilization measures
  Hospitalized, % 14.3 13.9 −0.4 .002
  Primary care visits, mean 5.1 5.4 10.4 .006
  Specialty care visits, mean 3.0 3.1 10.1 .22
 Cost measures, $, mean
  Total costs 7,260 6,594 −666 .12
  Inpatient costs† 13,273 14,117 1844 .69
  Primary care 970 1,043 173 .03
  Specialty care 945 904 −41 .44
Year 2,*,† 1,718 968
 Utilization measures
  Hospitalized, % 13.4% 13.2% −0.2% .07
  Primary care visits, mean 5.3 5.4 10.1 .54
  Specialty care visits, mean 3.2 3.4 10.2 .10
 Cost measures, $, mean
  Total costs 7,979 6,793 −1,186 .005
  Inpatient costs† 14,125 10,741 −3,384 .02
  Primary care 990 1,091 1101 .03
  Specialty care 1,032 980 −52 .32
Note: Predicted adjusted follow-up costs or utilization for participants from ordinary least squares (OLS) regression models adjusted for age, sex,
prevention sum, RxRisk (chronic disease score), any arthritis visits, diabetes mellitus registry, heart registry, and baseline measure for dependent
variable. P-values derived using robust standard error estimates from OLS (cost and utilization) or logistic (% hospitalized) regression; all costs in
2005 U.S. dollars.
*
Year 1 comparisons include all members (2,462 controls; 1,188 EF users) with cost and utilization data available continuously or months 0 to 12
after the index date. Year 2 comparisons include all members (1,718 controls; 968 EF users) included in the Year 1 sample with cost and utilization
data available for months 13–24 after the index date.
†
Inpatient costs only or individuals who had any inpatient utilization during the Year 1 (or Year 2) evaluation period.
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